At ProQR, our mission is to edit RNA, treat disease and change lives. This guides every decision we make as we work to develop new treatment options for people living with high unmet need.
Our vision is to create a world where genetics informs your health - but never limit it. By harnessing the power of RNA editing, we strive to make our vision for the future a reality.
At ProQR, we are dedicated to improving the lives of patients and families affected by rare and common disorders using Axiomer, our innovative RNA editing platform technology.
Find out how ProQR’s stock is trading now and in the past. Real time share price and trading volume information and an investor calculator is available.
This website contains forward-looking statements about potential therapeutic uses and effects of ProQR Therapeutics’ products, including but not limited to our technologies.
ProQR invented an entirely new way to treat genetic diseases. Axiomer enables RNA base editing by recruiting ADAR so your own body can treat disease. Learn more here.
What is RNA and how can we use the body's own RNA editing machinery to treat disease? Learn more about the Axiomer® RNA editing technology and how we are creating a new class of medicines.
At ProQR, we are dedicated to improving the lives of patients and families affected by rare and common disorders using Axiomer, our innovative RNA editing platform technology.
